US70261F1113 - KTTAW (XNAS)

Pasithea Therapeutics Corp. - Warrant Share

0,02 USD

-7,94 % -0,002 USD 11.12.2024 16:44 - USD - NASDAQ (XNAS) - Current prices and charts at MoneyPeak

Current Prices from Pasithea Therapeutics Corp. - Warrant

Exchange	Ticker	Currency	Last Trade	Price	Daily Change	Daily Change %
NASDAQ	KTTAW	USD	11.12.2024 16:44	0,02 USD	0,02 USD	-7,94 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	0,00 %	15,00 %	29,94 %	35,29 %	130,00 %	-97,36 %

Company Profile for Pasithea Therapeutics Corp. - Warrant Share

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.

Company Data for Pasithea Therapeutics Corp. - Warrant Share

Name Pasithea Therapeutics Corp. - Warrant

Company Pasithea Therapeutics Corp.

Symbol KTTAW

Website http://pasitheaclinics.com

Primary Exchange

NASDAQ

ISIN US70261F1113

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Tiago Reis Marques M.D., Ph.D.

Country United States of America

Currency USD

Employees 0,0 T

Address 1111 Lincoln Road, 33139 Miami Beach

IPO Date 2021-09-15

Ticker Symbols

Name	Symbol
NASDAQ	KTTAW

More Shares

Investors who Pasithea Therapeutics Corp. - Warrant hold also have the following shares in their portfolio:

AIIB 23/28 MTN Bond

DK MSCI USA MC ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog